Skip to main content

Advertisement

Log in

Germline mosaicism is a pitfall in the diagnosis of “sporadic” X-linked Alport syndrome

  • Case Report
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Approximately 80% of patients with Alport syndrome have X-linked Alport syndrome (XLAS), which is caused by mutations in the type IV collagen alpha 5 gene (COL4A5). In patients with XLAS, approximately 10–15% of COL4A5 mutations occur as spontaneous events. Here, we describe maternal germline mosaicism in a family of XLAS patients. Since our patient’s parents showed normal urinary findings without COL4A5 mutation using genomic DNA isolated from peripheral leukocytes, the patient was initially diagnosed with “sporadic” XLAS. However, genetic analysis of the patient’s sister with microscopic hematuria identified the same COL4A5 heterozygous mutation. Therefore, we concluded that our patient and the sister had XLAS caused by maternal germline mosaicism, not “sporadic” XLAS. Our case suggests that “sporadic” XLAS may in some patients be caused by the transmission of an abnormal allele from either parent with germline mosaicism in COL4A5. Germline mosaicism is thought to be rare, but we should consider that even asymptomatic parents of “sporadic” XLAS patients could carry a somatic and/or germline mosaicism. More cautious genetic counseling is advisable for all “sporadic” XLAS patients. Furthermore, urinalysis screening of “sporadic” XLAS patients’ siblings is also important to enable an earlier detection of parental germline mosaicism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Rheault MN, Kashtan CE (2016) Inherited glomerular diseases. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (eds) Pediatric nephrology. Springer, Berlin, pp 777–803. https://doi.org/10.1007/978-3-662-43596-0_79

    Chapter  Google Scholar 

  2. Plant KE, Boye E, Green PM, Vetrie D, Flinter FA (2000) Somatic mosaicism associated with a mild Alport syndrome phenotype. J Med Genet 37(3):238–239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Krol RP, Nozu K, Nakanishi K, Iijima K, Takeshima Y, Fu XJ, Nozu Y, Kaito H, Kanda K, Matsuo M, Yoshikawa N (2008) Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol Dial Transplant 23(8):2525–2530. https://doi.org/10.1093/ndt/gfn005

    Article  CAS  PubMed  Google Scholar 

  4. Fu XJ, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K, Yoshikawa N, Ohtsubo H, Matsunoshita N, Kamiyoshi N, Matsumura C, Takagi N, Maekawa K, Taniguchi-Ikeda M, Iijima K (2016) Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet 24(3):387–391. https://doi.org/10.1038/ejhg.2015.113

    Article  CAS  PubMed  Google Scholar 

  5. Bruttini M, Vitelli F, Meloni I, Rizzari G, Volpe MD, Mazzucco G, Marchi MD, Renieri A (2000) Mosaicism in Alport syndrome with genetic counselling. J Med Genet 37(9):717–719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Beicht S, Strobl-Wildemann G, Rath S, Wachter O, Alberer M, Kaminsky E, Weber LT, Hinrichsen T, Klein HG, Hoefele J (2013) Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene 526(2):474–477. https://doi.org/10.1016/j.gene.2013.05.045

    Article  CAS  PubMed  Google Scholar 

  7. Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H, Hamada R, Nozu Y, Shono A, Ninchoji T, Morisada N, Ishimori S, Fujimura J, Horinouchi T, Kaito H, Nakanishi K, Morioka I, Taniguchi-Ikeda M, Iijima K (2017) Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol 21(5):877–883. https://doi.org/10.1007/s10157-016-1352-y

    Article  CAS  PubMed  Google Scholar 

  8. Plevova P, Gut J, Janda J (2017) Familial hematuria: a review. Medicina (Kaunas) 53(1):1–10. https://doi.org/10.1016/j.medici.2017.01.002

    Article  Google Scholar 

  9. Zlotogora J (1998) Germ line mosaicism. Hum Genet 102(4):381–386

    Article  CAS  PubMed  Google Scholar 

  10. Gajecka M (2016) Unrevealed mosaicism in the next-generation sequencing era. Mol Genet Genom 291(2):513–530. https://doi.org/10.1007/s00438-015-1130-7

    Article  CAS  Google Scholar 

  11. Miyatake S, Koshimizu E, Hayashi YK, Miya K, Shiina M, Nakashima M, Tsurusaki Y, Miyake N, Saitsu H, Ogata K, Nishino I, Matsumoto N (2014) Deep sequencing detects very-low-grade somatic mosaicism in the unaffected mother of siblings with nemaline myopathy. Neuromuscul Disord 24(7):642–647. https://doi.org/10.1016/j.nmd.2014.04.002

    Article  PubMed  Google Scholar 

  12. Liehr T, Klein E, Mrasek K, Kosyakova N, Guilherme RS, Aust N, Venner C, Weise A, Hamid AB (2013) Clinical impact of somatic mosaicism in cases with small supernumerary marker chromosomes. Cytogenet Genome Res 139(3):158–163. https://doi.org/10.1159/000346026

    Article  CAS  PubMed  Google Scholar 

  13. Hall JG (1988) Review and hypotheses: somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 43(4):355–363

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Masanori Nakanishi and Ryota Suzuki (Department of Pediatrics, Kushiro Red Cross Hospital, Kushiro, Japan) for providing us medical information on the patient and his family. We also thank Tomohiko Yamamura and Tomoko Horinouchi (Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan) for genetic examinations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takayuki Okamoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

40620_2018_518_MOESM1_ESM.tif

Sequencing results of the patient’s mother to evaluate the existence of somatic mosaicism. Sanger sequence of saliva and urinary cells was also performed in the patient’s mother, resulting in no COL4A5 mutations in these samples or in her peripheral leukocytes (TIF 9442 KB)

40620_2018_518_MOESM2_ESM.tif

Targeted sequence analysis for genomic DNA extracted from saliva and peripheral leukocytes to pick up low grade mosaicism in somatic cells. No variant was detected in both samples although the NGS depth was 179 and 259 respectively. These results indicated the existence of maternal germline mosaicism without somatic mosaicism in COL4A5. (TIF 26584 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okamoto, T., Nozu, K., Iijima, K. et al. Germline mosaicism is a pitfall in the diagnosis of “sporadic” X-linked Alport syndrome. J Nephrol 32, 155–159 (2019). https://doi.org/10.1007/s40620-018-0518-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-018-0518-y

Keywords

Navigation